These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 16648142)

  • 1. Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells.
    Munchhof AM; Li F; White HA; Mead LE; Krier TR; Fenoglio A; Li X; Yuan J; Yang FC; Ingram DA
    Hum Mol Genet; 2006 Jun; 15(11):1858-69. PubMed ID: 16648142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells.
    Mashour GA; Ratner N; Khan GA; Wang HL; Martuza RL; Kurtz A
    Oncogene; 2001 Jan; 20(1):97-105. PubMed ID: 11244508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nf1 haploinsufficiency augments angiogenesis.
    Wu M; Wallace MR; Muir D
    Oncogene; 2006 Apr; 25(16):2297-303. PubMed ID: 16288202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells.
    Yang FC; Ingram DA; Chen S; Hingtgen CM; Ratner N; Monk KR; Clegg T; White H; Mead L; Wenning MJ; Williams DA; Kapur R; Atkinson SJ; Clapp DW
    J Clin Invest; 2003 Dec; 112(12):1851-61. PubMed ID: 14679180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumorigenic properties of neurofibromin-deficient Schwann cells in culture and as syngrafts in Nf1 knockout mice.
    Wu M; Wallace MR; Muir D
    J Neurosci Res; 2005 Nov; 82(3):357-67. PubMed ID: 16180234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100B and neurofibromin immunostaining and X-inactivation patterns of laser-microdissected cells indicate a multicellular origin of some NF1-associated neurofibromas.
    Tucker T; Riccardi VM; Brown C; Fee J; Sutcliffe M; Vielkind J; Wechsler J; Wolkenstein P; Friedman JM
    J Neurosci Res; 2011 Sep; 89(9):1451-60. PubMed ID: 21674567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of neurofibromin contributes to epithelial-mesenchymal transition in neurofibromatosis type 1.
    Arima Y; Hayashi H; Kamata K; Goto TM; Sasaki M; Kuramochi A; Saya H
    Exp Dermatol; 2010 Aug; 19(8):e136-41. PubMed ID: 20002172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plexiform-like neurofibromas develop in the mouse by intraneural xenograft of an NF1 tumor-derived Schwann cell line.
    Perrin GQ; Fishbein L; Thomson SA; Thomas SL; Stephens K; Garbern JY; DeVries GH; Yachnis AT; Wallace MR; Muir D
    J Neurosci Res; 2007 May; 85(6):1347-57. PubMed ID: 17335073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of hormones and hormone metabolites on the growth of Schwann cells derived from embryonic stem cells and on tumor cell lines expressing variable levels of neurofibromin.
    Roth TM; Ramamurthy P; Muir D; Wallace MR; Zhu Y; Chang L; Barald KF
    Dev Dyn; 2008 Feb; 237(2):513-24. PubMed ID: 18213578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tumor suppressor neurofibromin confers sensitivity to apoptosis by Ras-dependent and Ras-independent pathways.
    Shapira S; Barkan B; Friedman E; Kloog Y; Stein R
    Cell Death Differ; 2007 May; 14(5):895-906. PubMed ID: 17096025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reconstitution of the NF1 GAP-related domain in NF1-deficient human Schwann cells.
    Thomas SL; Deadwyler GD; Tang J; Stubbs EB; Muir D; Hiatt KK; Clapp DW; De Vries GH
    Biochem Biophys Res Commun; 2006 Sep; 348(3):971-80. PubMed ID: 16908010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofibromin, the neurofibromatosis type 1 Ras-GAP, is required for appropriate P0 expression and myelination.
    Rosenbaum T; Kim HA; Boissy YL; Ling B; Ratner N
    Ann N Y Acad Sci; 1999 Sep; 883():203-14. PubMed ID: 10586246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofibromin-deficient Schwann cells have increased lysophosphatidic acid dependent survival and migration-implications for increased neurofibroma formation during pregnancy.
    Nebesio TD; Ming W; Chen S; Clegg T; Yuan J; Yang Y; Estwick SA; Li Y; Li X; Hingtgen CM; Yang FC
    Glia; 2007 Apr; 55(5):527-36. PubMed ID: 17236191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma.
    Dasgupta B; Yi Y; Hegedus B; Weber JD; Gutmann DH
    Cancer Res; 2005 Nov; 65(21):9843-50. PubMed ID: 16267007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes.
    Kim HA; Rosenbaum T; Marchionni MA; Ratner N; DeClue JE
    Oncogene; 1995 Jul; 11(2):325-35. PubMed ID: 7624147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning.
    Yu X; Chen S; Potter OL; Murthy SM; Li J; Pulcini JM; Ohashi N; Winata T; Everett ET; Ingram D; Clapp WD; Hock JM
    Bone; 2005 May; 36(5):793-802. PubMed ID: 15804420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth.
    Daginakatte GC; Gutmann DH
    Hum Mol Genet; 2007 May; 16(9):1098-112. PubMed ID: 17400655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. It takes two to tango: mast cell and Schwann cell interactions in neurofibromas.
    Viskochil DH
    J Clin Invest; 2003 Dec; 112(12):1791-3. PubMed ID: 14679174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mouse embryonic stem cell model of Schwann cell differentiation for studies of the role of neurofibromatosis type 1 in Schwann cell development and tumor formation.
    Roth TM; Ramamurthy P; Ebisu F; Lisak RP; Bealmear BM; Barald KF
    Glia; 2007 Aug; 55(11):1123-33. PubMed ID: 17597122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
    Barkan B; Starinsky S; Friedman E; Stein R; Kloog Y
    Clin Cancer Res; 2006 Sep; 12(18):5533-42. PubMed ID: 17000690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.